deCODE scientists discover genetic markers to improve prostate cancer test accuracy
Scientists from deCODE genetics have discovered genetic markers which improve the accuracy of prostate specific antigen (PSA) testing…
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
16 Dec 10
Scientists from deCODE genetics have discovered genetic markers which improve the accuracy of prostate specific antigen (PSA) testing…
16 Dec 10
NextGen Healthcare Information Systems, a wholly owned subsidiary of Quality Systems, and a provider of healthcare information systems…
16 Dec 10
Curvus, the wholly-owned subsidiary of WPR Medical AS and developer of real-time, wireless solutions for remotely monitoring clinical…
16 Dec 10
Accuray has received 510(k) clearance from the US Food and Drug Administration (FDA) for Lung Optimized Treatment, a…
16 Dec 10
Bruker has received a major order from the University of British Columbia for its ultra-high field AVANCE III…
16 Dec 10
OSI Systems' Healthcare division, Spacelabs Healthcare, has received a $2.9m contract from a prominent Louisiana based hospital to…
16 Dec 10
Imaging Diagnostic Systems (IDSI), a provider of laser breast imaging, has received deposits for two Computed Tomography Laser…
16 Dec 10
iTech Medical, a medical information technology company, has received CE mark approval for the commercial sale of the…
16 Dec 10
Amoy Diagnostics (AmoyDx) has received marketing approval from China's State Food and Drug Administration (SFDA) for its KRAS…
16 Dec 10
Pico-Tesla, The Magneceutical Company, has commenced a randomized, double-blind, placebo-controlled pilot study of 30 patients having fibromyalgia.